Anil Agarwal
Nephrology · Columbus, OHNPI 1639115413
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $70,409 of the $99,228 with a category attached, or 71.0%. 12 manufacturers reported payments, led by Cormedix Inc. at 39.0% of the total. 2025 is the largest year on record at $32,508, 2.7 times the $12,139 reported in 2019. Among nephrology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 85 payments — averaging $1167.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cormedix Inc.$39K
- AstraZeneca$22K
- Johnson & Johnson$13K
- Amgen$8K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$6K
- Akebia Therapeutics Inc$5K
- plus $7K from 6 others
Across 29 payments — averaging $1504.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Akebia Therapeutics Inc$31K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$10K
- Vertex$3K
What the payments were for
- Consulting fees$70,40971%
- Speaking & faculty fees$26,14126%
- Travel & lodging$1,7552%
- Food & beverage$8641%
- Education$580%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cormedix Inc. | 6 | $38,658 |
| AstraZeneca | 32 | $21,935 |
| Johnson & Johnson | 22 | $12,801 |
| Amgen | 4 | $7,662 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 4 | $5,625 |
| Akebia Therapeutics Inc | 3 | $5,435 |
| Rockwell Medical, Inc. | 2 | $3,276 |
| Otsuka America Pharmaceutical, Inc. | 4 | $1,960 |
| Pfizer | 1 | $1,800 |
| Calliditas Therapeutics US Inc. | 2 | $36 |
| Vifor Pharma, Inc. | 1 | $32 |
| Travere Therapeutics, Inc. | 4 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$99,228 in reported general payments places this provider in the 95th percentile of 450 nephrology providers in Ohio.
Other nephrology in Columbus
- Brad RovinColumbus$379K
- Samir ParikhColumbus$145K
- Isabelle AyoubColumbus$116K
- Karim AttiaColumbus$43K
- Rima KangColumbus$28K
- Salem AlmaaniColumbus$21K
- Todd PesaventoColumbus$20K
- Naveen SingriColumbus$11K
- Jessica GrecoColumbus$11K
- Jason ProsekColumbus$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.